“Synthesis and in silico study of 2-furyl(4-{4-[(substituted)sulfonyl]benzyl}-1-piperazinyl)methanone derivatives as suitable therapeutic agents”, Braz. J. Pharm. Sci., vol. 53, no. 1, p. e15237-, Jan. 2017, doi: 10.1590/s2175-97902017000115237.